サンプル依頼リスト カート
  • English
デフォルト表紙
市場調査レポート
商品コード
1739207

末梢動脈疾患の世界市場

Peripheral Artery Disease

出版日
ページ情報
英文 265 Pages
納期
即日から翌営業日
適宜更新あり
価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=144.76円
末梢動脈疾患の世界市場
出版日: 2025年05月23日
発行: Global Industry Analysts, Inc.
ページ情報: 英文 265 Pages
納期: 即日から翌営業日
GIIご利用のメリット
  • 全表示
  • 概要
  • 目次
概要

末梢動脈疾患の世界市場は2030年までに70億米ドルに達する見込み

2024年に47億米ドルと推定される末梢動脈疾患の世界市場は、2024年から2030年にかけてCAGR 6.8%で成長し、2030年には70億米ドルに達すると予測されます。本レポートで分析したセグメントの1つであるデバイスは、CAGR 8.0％を記録し、分析期間終了時には47億米ドルに達すると予測されます。医薬品セグメントの成長率は、分析期間中CAGR 4.6%と推定されます。

米国市場は13億米ドルと推定、中国はCAGR 10.9％で成長予測

米国の末梢動脈疾患市場は2024年に13億米ドルと推定されます。世界第2位の経済大国である中国は、2030年までに15億米ドルの市場規模に達すると予測され、分析期間2024-2030年のCAGRは10.9%です。その他の注目すべき地域別市場としては、日本とカナダがあり、分析期間中のCAGRはそれぞれ3.3％と6.7％と予測されています。欧州では、ドイツがCAGR 4.5%で成長すると予測されています。

世界の末梢動脈疾患市場- 主要動向と促進要因のまとめ

末梢動脈疾患が世界の主要な心血管健康問題として注目を集める理由とは？

末梢動脈疾患（PAD）は、動脈硬化性プラークの蓄積による主に下肢の動脈の狭窄や閉塞を特徴とし、世界的に重要な健康問題として認識されつつあります。世界中で2億人以上が罹患しているPADは、運動能力や生活の質を損なうだけでなく、心筋梗塞、脳卒中、四肢切断のリスクを著しく高める。特に高齢者、糖尿病患者、喫煙者におけるPADの増加は、早期診断、積極的な危険因子管理、利用しやすい治療法の必要性を強調しています。

PADを特に困難なものにしているのは、その過小診断であり、加齢や関節炎の症状として誤認されることが多く、介入の遅れにつながっていることです。一般の人々の認識が高まり、スクリーニング・プロトコルが改善されるにつれて、画像診断、血管評価、低侵襲治療に対する需要が加速しています。現在、世界中の医療システムがPADの検出を日常的な心臓血管治療や糖尿病管理プログラムに組み込んでおり、合併症の減少や長期的な血管転帰の改善を目的とした臨床的な焦点や治療上の革新を推進しています。

治療の進歩と低侵襲デバイスはどのようにPAD管理を形成しているか？

現代のPAD治療は、全身的な薬物療法にとどまらず、先進的な血管内治療や生物学的に工学的な治療戦略へと移行しつつあります。抗血小板薬、脂質低下薬、抗高血圧薬は依然としてリスク軽減の基礎となっています。しかし、バルーン血管形成術、薬剤溶出ステント（DES）、アテレクトミーシステム、薬剤コーティングバルーン（DCB）などのデバイスを用いたインターベンションは、特に生活制限性跛行や重症虚血肢（CLI）を有する患者の血行再建術にますます採用されるようになってきています。

技術革新は、再狭窄を減少させ、血管の開存性を改善するために、超薄型ストラット・プラットフォーム、生体吸収性ポリマー、標的薬剤放出機構などの特徴を備えたデバイス設計を強化しています。血管内超音波（IVUS），光干渉断層計（OCT），灌流画像などの補助的ツールは，手技の正確さと術後のモニタリングを向上させています。一方，複雑で再建不可能なPAD症例に対しては，自己幹細胞や血管新生成長因子を用いた再生療法が臨床的に評価されています。これらの進歩により、治療のパラダイムは、個別化され、四肢を救済し、侵襲の少ない管理へと移行しつつあります。

PAD診断と介入に対する需要を牽引しているリスクグループと世界の医療制度は？

PADは65歳以上、喫煙者、糖尿病、高血圧、脂質異常症、慢性腎臓病の患者に最も多くみられます。非伝染性疾患と座りがちなライフスタイルが都市部の人々に与える負担の増大は、PADをさらに公衆衛生の焦点に押し上げています。退役軍人、切断患者、術後患者もまた、血管モニタリングとリハビリテーション・ケアを必要とする重要な層を形成しています。集学的ケアモデルが拡大するにつれて、PADは循環器専門医、糖尿病専門医、血管外科医、プライマリ・ケア提供者と協力して管理されるようになってきています。

北米と西欧は、構造化された血管プログラム、保険償還、血管内治療ラボへのアクセスの普及により、診断率と介入率で市場をリードしています。しかし、アジア太平洋、特に中国、インド、日本は、人口動態の変化、糖尿病有病率の上昇、医療インフラの改善により、PAD介入において最も急速な成長を示しています。ラテンアメリカやアフリカの公衆衛生機関は、PADを非感染性疾患戦略の対象として認識し始めており、スクリーニングキャンペーン、トレーニング、器具の利用可能性への投資を促進しています。

PAD治療市場の長期的成長と戦略的革新の原動力は？

末梢動脈疾患市場の成長の原動力は、人口動態の高齢化、合併症率の上昇、薬物療法とインターベンション療法の両方の技術革新の融合です。PADが広範囲に影響を及ぼす全身性の血管障害として認知されるにつれ、ヘルスケア利害関係者は早期発見、長期的な監視、費用対効果の高い介入をますます優先するようになっています。患者参加型プラットフォーム、遠隔モニタリング、ウェアラブル診断も、アドヒアランスと遠隔追跡を改善するためにPAD管理に統合されつつあります。

戦略的には、企業は次世代薬剤とデバイスの組み合わせ、生体吸収性インプラント、AIを活用した画像診断ツールを開発し、治療成績を最適化し再発を減らしています。医療技術企業、学術機関、公衆衛生機関のパートナーシップは、新たな治療法を検証するための臨床試験や医療経済研究を促進しています。質調整生存年（QALY）と四肢救済アウトカムが重視される価値観に基づく医療モデルにより、PAD市場は、より広範な心血管治療展望の中で重要な焦点として、その軌道を継続すると予想されます。

セグメント

製品タイプ（デバイス、医薬品）;エンドユーザー（専門クリニック、病院）

調査対象企業の例（全34社）

  • Abbott Laboratories
  • AngioDynamics
  • B. Braun Melsungen AG
  • Bayer AG
  • Becton, Dickinson and Company
  • Biotronik
  • Boston Scientific Corporation
  • Cardinal Health
  • Cook Medical
  • Cordis
  • Endologix, Inc.
  • Johnson & Johnson MedTech
  • LeMaitre Vascular
  • Medtronic plc
  • Merit Medical Systems
  • OrbusNeich
  • Philips Healthcare
  • Shockwave Medical
  • Straub Medical AG
  • Terumo Corporation

関税影響係数

Global Industry Analystsは、本社の国、製造拠点、輸出入（完成品とOEM）に基づく企業の競争力の変化を予測しています。この複雑で多面的な市場力学は、人為的な売上原価の増加、収益性の低下、サプライチェーンの再構築など、ミクロおよびマクロの市場力学の中でも特に競合他社に影響を与える見込みです。

Global Industry Analystsは、世界の主要なチーフ・エコノミスト（1万4,949人）、シンクタンク（62団体）、貿易・産業団体（171団体）の専門家の意見に熱心に従いながら、エコシステムへの影響を評価し、新たな市場の現実に対処しています。あらゆる主要国の専門家やエコノミストが、関税とそれが自国に与える影響についての意見を追跡調査しています。

Global Industry Analystsは、この混乱が今後2-3ヶ月で収束し、新しい世界秩序がより明確に確立されると予想しています。Global Industry Analystsは、これらの開発をリアルタイムで追跡しています。

2025年4月：交渉フェーズ

4月のリリースでは、世界市場全体に対する関税の影響を取り上げ、地域別の市場調整について紹介します。当社の予測は、過去のデータと進化する市場影響要因に基づいています。

2025年7月：最終関税リセット

お客様には、各国間で最終リセットが発表された後、7月に無料アップデート版をお届けします。最終アップデート版には、明確に定義された関税影響分析が組み込まれています。

相互および二国間貿易と関税の影響分析：

アメリカ <>中国<>メキシコ <>カナダ <>EU <>日本<>インド <>その他176カ国

業界をリードするエコノミスト：Global Industry Analystsの知識ベースは、国家、シンクタンク、貿易・産業団体、大企業、そして世界の計量経済状況におけるこの前例のないパラダイムシフトの影響を共有する領域の専門家など、最も影響力のあるチーフエコノミストの厳選されたグループを含む1万4,949人のエコノミストを追跡しています。我々の16,491以上のレポートのほとんどは、マイルストーンに基づくこの2段階のリリーススケジュールを取り入れています。

目次

第1章 調査手法

第2章 エグゼクティブサマリー

  • 市場概要
  • 主要企業
  • 市場動向と促進要因
  • 世界市場の見通し

第3章 市場分析

  • 米国
  • カナダ
  • 日本
  • 中国
  • 欧州
  • フランス
  • ドイツ
  • イタリア
  • 英国
  • スペイン
  • ロシア
  • その他欧州
  • アジア太平洋
  • オーストラリア
  • インド
  • 韓国
  • その他アジア太平洋地域
  • ラテンアメリカ
  • アルゼンチン
  • ブラジル
  • メキシコ
  • その他ラテンアメリカ
  • 中東
  • イラン
  • イスラエル
  • サウジアラビア
  • アラブ首長国連邦
  • その他中東
  • アフリカ

第4章 競合

目次
Product Code: MCP34179

Global Peripheral Artery Disease Market to Reach US$7.0 Billion by 2030

The global market for Peripheral Artery Disease estimated at US$4.7 Billion in the year 2024, is expected to reach US$7.0 Billion by 2030, growing at a CAGR of 6.8% over the analysis period 2024-2030. Devices, one of the segments analyzed in the report, is expected to record a 8.0% CAGR and reach US$4.7 Billion by the end of the analysis period. Growth in the Drugs segment is estimated at 4.6% CAGR over the analysis period.

The U.S. Market is Estimated at US$1.3 Billion While China is Forecast to Grow at 10.9% CAGR

The Peripheral Artery Disease market in the U.S. is estimated at US$1.3 Billion in the year 2024. China, the world's second largest economy, is forecast to reach a projected market size of US$1.5 Billion by the year 2030 trailing a CAGR of 10.9% over the analysis period 2024-2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at a CAGR of 3.3% and 6.7% respectively over the analysis period. Within Europe, Germany is forecast to grow at approximately 4.5% CAGR.

Global Peripheral Artery Disease Market - Key Trends & Drivers Summarized

Why Is Peripheral Artery Disease Gaining Attention as a Major Global Cardiovascular Health Concern?

Peripheral Artery Disease (PAD), characterized by the narrowing or blockage of arteries-primarily in the lower extremities-due to atherosclerotic plaque buildup, is increasingly being recognized as a critical global health issue. Affecting over 200 million people worldwide, PAD not only impairs mobility and quality of life but also significantly elevates the risk of myocardial infarction, stroke, and limb amputation. Its growing prevalence, particularly among aging populations, diabetics, and smokers, underscores the need for early diagnosis, aggressive risk factor management, and accessible treatment options.

What makes PAD particularly challenging is its underdiagnosis and frequent misidentification as a symptom of aging or arthritis, leading to delayed interventions. As public awareness increases and screening protocols improve, the demand for diagnostic imaging, vascular assessments, and minimally invasive therapies is accelerating. Health systems worldwide are now integrating PAD detection into routine cardiovascular care and diabetes management programs, propelling clinical focus and therapeutic innovation aimed at reducing complications and improving long-term vascular outcomes.

How Are Therapeutic Advances and Minimally Invasive Devices Shaping PAD Management?

Modern PAD treatment is moving beyond systemic pharmacotherapy to include advanced endovascular interventions and biologically engineered therapeutic strategies. Antiplatelet agents, lipid-lowering drugs, and antihypertensives remain foundational in risk mitigation. However, device-based interventions such as balloon angioplasty, drug-eluting stents (DES), atherectomy systems, and drug-coated balloons (DCBs) are being increasingly adopted for revascularization, especially in patients with lifestyle-limiting claudication or critical limb ischemia (CLI).

Technological innovation is enhancing device design with features like ultrathin strut platforms, bioresorbable polymers, and targeted drug release mechanisms to reduce restenosis and improve vessel patency. Adjunctive tools such as intravascular ultrasound (IVUS), optical coherence tomography (OCT), and perfusion imaging are improving procedural accuracy and post-operative monitoring. Meanwhile, regenerative therapies involving autologous stem cells and angiogenic growth factors are under clinical evaluation for complex and non-reconstructable PAD cases. These advancements are shifting the treatment paradigm toward personalized, limb-salvaging, and less invasive management.

Which Risk Groups and Global Health Systems Are Driving Demand for PAD Diagnostics and Interventions?

PAD is most prevalent among individuals over 65, smokers, patients with diabetes mellitus, hypertension, dyslipidemia, and chronic kidney disease. The growing burden of noncommunicable diseases and sedentary lifestyles in urban populations is pushing PAD further into public health focus. Veterans, amputees, and post-operative patients also form significant segments requiring vascular monitoring and rehabilitative care. As multidisciplinary care models expand, PAD is increasingly managed in collaboration with cardiologists, diabetologists, vascular surgeons, and primary care providers.

North America and Western Europe lead the market in terms of diagnosis and intervention rates, owing to structured vascular programs, reimbursement coverage, and widespread access to endovascular labs. However, Asia-Pacific-particularly China, India, and Japan-is witnessing the fastest growth in PAD interventions due to demographic shifts, rising diabetes prevalence, and improving healthcare infrastructure. Public health agencies in Latin America and Africa are beginning to recognize PAD as a target for noncommunicable disease strategies, driving investments in screening campaigns, training, and device accessibility.

What Is Driving Long-Term Growth and Strategic Innovation in the PAD Treatment Market?

The growth in the peripheral artery disease market is driven by a convergence of aging demographics, rising comorbidity rates, and innovations in both pharmaceutical and interventional therapies. As PAD gains recognition as a systemic vascular disorder with far-reaching consequences, healthcare stakeholders are increasingly prioritizing early detection, long-term surveillance, and cost-effective interventions. Patient engagement platforms, telemonitoring, and wearable diagnostics are also being integrated into PAD management to improve adherence and remote tracking.

Strategically, companies are developing next-generation drug-device combinations, bioabsorbable implants, and AI-powered imaging tools to optimize procedural outcomes and reduce recurrence. Partnerships between medtech firms, academic institutions, and public health bodies are fostering clinical trials and health economic studies to validate emerging therapies. As value-based care models emphasize quality-adjusted life years (QALYs) and limb salvage outcomes, the PAD market is expected to continue its trajectory as a key focus within the broader cardiovascular therapeutics landscape.

SCOPE OF STUDY:

The report analyzes the Peripheral Artery Disease market in terms of units by the following Segments, and Geographic Regions/Countries:

Segments:

Product Type (Devices, Drugs); End-User (Specialty Clinics, Hospitals)

Geographic Regions/Countries:

World; United States; Canada; Japan; China; Europe (France; Germany; Italy; United Kingdom; Spain; Russia; and Rest of Europe); Asia-Pacific (Australia; India; South Korea; and Rest of Asia-Pacific); Latin America (Argentina; Brazil; Mexico; and Rest of Latin America); Middle East (Iran; Israel; Saudi Arabia; United Arab Emirates; and Rest of Middle East); and Africa.

Select Competitors (Total 34 Featured) -

  • Abbott Laboratories
  • AngioDynamics
  • B. Braun Melsungen AG
  • Bayer AG
  • Becton, Dickinson and Company
  • Biotronik
  • Boston Scientific Corporation
  • Cardinal Health
  • Cook Medical
  • Cordis
  • Endologix, Inc.
  • Johnson & Johnson MedTech
  • LeMaitre Vascular
  • Medtronic plc
  • Merit Medical Systems
  • OrbusNeich
  • Philips Healthcare
  • Shockwave Medical
  • Straub Medical AG
  • Terumo Corporation

TARIFF IMPACT FACTOR

Our new release incorporates impact of tariffs on geographical markets as we predict a shift in competitiveness of companies based on HQ country, manufacturing base, exports and imports (finished goods and OEM). This intricate and multifaceted market reality will impact competitors by artificially increasing the COGS, reducing profitability, reconfiguring supply chains, amongst other micro and macro market dynamics.

We are diligently following expert opinions of leading Chief Economists (14,949), Think Tanks (62), Trade & Industry bodies (171) worldwide, as they assess impact and address new market realities for their ecosystems. Experts and economists from every major country are tracked for their opinions on tariffs and how they will impact their countries.

We expect this chaos to play out over the next 2-3 months and a new world order is established with more clarity. We are tracking these developments on a real time basis.

As we release this report, U.S. Trade Representatives are pushing their counterparts in 183 countries for an early closure to bilateral tariff negotiations. Most of the major trading partners also have initiated trade agreements with other key trading nations, outside of those in the works with the United States. We are tracking such secondary fallouts as supply chains shift.

To our valued clients, we say, we have your back. We will present a simplified market reassessment by incorporating these changes!

APRIL 2025: NEGOTIATION PHASE

Our April release addresses the impact of tariffs on the overall global market and presents market adjustments by geography. Our trajectories are based on historic data and evolving market impacting factors.

JULY 2025 FINAL TARIFF RESET

Complimentary Update: Our clients will also receive a complimentary update in July after a final reset is announced between nations. The final updated version incorporates clearly defined Tariff Impact Analyses.

Reciprocal and Bilateral Trade & Tariff Impact Analyses:

USA <> CHINA <> MEXICO <> CANADA <> EU <> JAPAN <> INDIA <> 176 OTHER COUNTRIES.

Leading Economists - Our knowledge base tracks 14,949 economists including a select group of most influential Chief Economists of nations, think tanks, trade and industry bodies, big enterprises, and domain experts who are sharing views on the fallout of this unprecedented paradigm shift in the global econometric landscape. Most of our 16,491+ reports have incorporated this two-stage release schedule based on milestones.

COMPLIMENTARY PREVIEW

Contact your sales agent to request an online 300+ page complimentary preview of this research project. Our preview will present full stack sources, and validated domain expert data transcripts. Deep dive into our interactive data-driven online platform.

TABLE OF CONTENTS

I. METHODOLOGY

II. EXECUTIVE SUMMARY

  • 1. MARKET OVERVIEW
    • Influencer Market Insights
    • World Market Trajectories
    • Impact of Covid-19 and a Looming Global Recession
    • Peripheral Artery Disease - Global Key Competitors Percentage Market Share in 2025 (E)
    • Competitive Market Presence - Strong/Active/Niche/Trivial for Players Worldwide in 2025 (E)
  • 2. FOCUS ON SELECT PLAYERS
  • 3. MARKET TRENDS & DRIVERS
    • Rising Global Burden of Atherosclerosis Propels Demand for Peripheral Artery Disease Management Solutions
    • Increase in Diabetic and Elderly Populations Throws the Spotlight on Early PAD Screening and Treatment
    • Advancements in Drug-Coated Balloons and Stents Drive Minimally Invasive Treatment Options
    • Expansion of Endovascular and Hybrid Procedures Strengthens Business Case for Hospital-Based PAD Care
    • Growth in Use of Duplex Ultrasound and Non-Invasive Vascular Testing Enhances PAD Diagnosis Accuracy
    • Development of Next-Generation Atherectomy Devices Supports Removal of Complex Lesions
    • Increased Use of Antiplatelet and Lipid-Lowering Therapies Sustains Medical Management Segment
    • Rising Reimbursement Approvals for PAD Interventions Expand Access to Vascular Procedures
    • Surge in Ambulatory Surgical Centers Offering PAD Treatment Fuels Procedural Volume Growth
    • Integration of AI and Wearable Monitoring Devices Supports Real-Time PAD Progression Tracking
    • Regulatory Approvals for Breakthrough PAD Devices Accelerate Commercialization in High-Risk Cohorts
    • Expansion of Multidisciplinary Vascular Care Models Enhances Patient Outcomes and Continuity of Care
    • Growing Awareness Campaigns on Claudication and Limb Loss Risks Spur Early PAD Screening
    • Availability of Bioabsorbable Scaffolds and Resorbable Implants Drives Innovation in PAD Treatment
    • Collaboration Between Device Manufacturers and Cardiologists Enhances Clinical Data Generation
    • Focus on PAD in Underserved Populations and Rural Areas Strengthens Tele-Vascular Consultation Uptake
    • Implementation of Standardized Treatment Protocols Promotes Evidence-Based Intervention Strategies
    • Challenges in Restenosis and Long-Term Patency Spur Research in Coated and Targeted Delivery Systems
    • Expansion of PAD Clinical Trials and Registries Supports Real-World Data for Device Evaluation
    • Use of Multimodal Imaging in Peripheral Revascularization Improves Procedure Planning and Guidance
  • 4. GLOBAL MARKET PERSPECTIVE
    • TABLE 1: World Peripheral Artery Disease Market Analysis of Annual Sales in US$ Million for Years 2015 through 2030
    • TABLE 2: World Recent Past, Current & Future Analysis for Peripheral Artery Disease by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 3: World Historic Review for Peripheral Artery Disease by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 4: World 15-Year Perspective for Peripheral Artery Disease by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets for Years 2015, 2025 & 2030
    • TABLE 5: World Recent Past, Current & Future Analysis for Devices by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 6: World Historic Review for Devices by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 7: World 15-Year Perspective for Devices by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 8: World Recent Past, Current & Future Analysis for Drugs by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 9: World Historic Review for Drugs by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 10: World 15-Year Perspective for Drugs by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 11: World Recent Past, Current & Future Analysis for Specialty Clinics by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 12: World Historic Review for Specialty Clinics by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 13: World 15-Year Perspective for Specialty Clinics by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 14: World Recent Past, Current & Future Analysis for Hospitals by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 15: World Historic Review for Hospitals by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 16: World 15-Year Perspective for Hospitals by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030

III. MARKET ANALYSIS

  • UNITED STATES
    • Peripheral Artery Disease Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United States for 2025 (E)
    • TABLE 17: USA Recent Past, Current & Future Analysis for Peripheral Artery Disease by Product Type - Devices and Drugs - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 18: USA Historic Review for Peripheral Artery Disease by Product Type - Devices and Drugs Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 19: USA 15-Year Perspective for Peripheral Artery Disease by Product Type - Percentage Breakdown of Value Sales for Devices and Drugs for the Years 2015, 2025 & 2030
    • TABLE 20: USA Recent Past, Current & Future Analysis for Peripheral Artery Disease by End-user - Specialty Clinics and Hospitals - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 21: USA Historic Review for Peripheral Artery Disease by End-user - Specialty Clinics and Hospitals Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 22: USA 15-Year Perspective for Peripheral Artery Disease by End-user - Percentage Breakdown of Value Sales for Specialty Clinics and Hospitals for the Years 2015, 2025 & 2030
  • CANADA
    • TABLE 23: Canada Recent Past, Current & Future Analysis for Peripheral Artery Disease by Product Type - Devices and Drugs - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 24: Canada Historic Review for Peripheral Artery Disease by Product Type - Devices and Drugs Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 25: Canada 15-Year Perspective for Peripheral Artery Disease by Product Type - Percentage Breakdown of Value Sales for Devices and Drugs for the Years 2015, 2025 & 2030
    • TABLE 26: Canada Recent Past, Current & Future Analysis for Peripheral Artery Disease by End-user - Specialty Clinics and Hospitals - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 27: Canada Historic Review for Peripheral Artery Disease by End-user - Specialty Clinics and Hospitals Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 28: Canada 15-Year Perspective for Peripheral Artery Disease by End-user - Percentage Breakdown of Value Sales for Specialty Clinics and Hospitals for the Years 2015, 2025 & 2030
  • JAPAN
    • Peripheral Artery Disease Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Japan for 2025 (E)
    • TABLE 29: Japan Recent Past, Current & Future Analysis for Peripheral Artery Disease by Product Type - Devices and Drugs - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 30: Japan Historic Review for Peripheral Artery Disease by Product Type - Devices and Drugs Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 31: Japan 15-Year Perspective for Peripheral Artery Disease by Product Type - Percentage Breakdown of Value Sales for Devices and Drugs for the Years 2015, 2025 & 2030
    • TABLE 32: Japan Recent Past, Current & Future Analysis for Peripheral Artery Disease by End-user - Specialty Clinics and Hospitals - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 33: Japan Historic Review for Peripheral Artery Disease by End-user - Specialty Clinics and Hospitals Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 34: Japan 15-Year Perspective for Peripheral Artery Disease by End-user - Percentage Breakdown of Value Sales for Specialty Clinics and Hospitals for the Years 2015, 2025 & 2030
  • CHINA
    • Peripheral Artery Disease Market Presence - Strong/Active/Niche/Trivial - Key Competitors in China for 2025 (E)
    • TABLE 35: China Recent Past, Current & Future Analysis for Peripheral Artery Disease by Product Type - Devices and Drugs - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 36: China Historic Review for Peripheral Artery Disease by Product Type - Devices and Drugs Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 37: China 15-Year Perspective for Peripheral Artery Disease by Product Type - Percentage Breakdown of Value Sales for Devices and Drugs for the Years 2015, 2025 & 2030
    • TABLE 38: China Recent Past, Current & Future Analysis for Peripheral Artery Disease by End-user - Specialty Clinics and Hospitals - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 39: China Historic Review for Peripheral Artery Disease by End-user - Specialty Clinics and Hospitals Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 40: China 15-Year Perspective for Peripheral Artery Disease by End-user - Percentage Breakdown of Value Sales for Specialty Clinics and Hospitals for the Years 2015, 2025 & 2030
  • EUROPE
    • Peripheral Artery Disease Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Europe for 2025 (E)
    • TABLE 41: Europe Recent Past, Current & Future Analysis for Peripheral Artery Disease by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 42: Europe Historic Review for Peripheral Artery Disease by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 43: Europe 15-Year Perspective for Peripheral Artery Disease by Geographic Region - Percentage Breakdown of Value Sales for France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets for Years 2015, 2025 & 2030
    • TABLE 44: Europe Recent Past, Current & Future Analysis for Peripheral Artery Disease by Product Type - Devices and Drugs - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 45: Europe Historic Review for Peripheral Artery Disease by Product Type - Devices and Drugs Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 46: Europe 15-Year Perspective for Peripheral Artery Disease by Product Type - Percentage Breakdown of Value Sales for Devices and Drugs for the Years 2015, 2025 & 2030
    • TABLE 47: Europe Recent Past, Current & Future Analysis for Peripheral Artery Disease by End-user - Specialty Clinics and Hospitals - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 48: Europe Historic Review for Peripheral Artery Disease by End-user - Specialty Clinics and Hospitals Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 49: Europe 15-Year Perspective for Peripheral Artery Disease by End-user - Percentage Breakdown of Value Sales for Specialty Clinics and Hospitals for the Years 2015, 2025 & 2030
  • FRANCE
    • Peripheral Artery Disease Market Presence - Strong/Active/Niche/Trivial - Key Competitors in France for 2025 (E)
    • TABLE 50: France Recent Past, Current & Future Analysis for Peripheral Artery Disease by Product Type - Devices and Drugs - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 51: France Historic Review for Peripheral Artery Disease by Product Type - Devices and Drugs Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 52: France 15-Year Perspective for Peripheral Artery Disease by Product Type - Percentage Breakdown of Value Sales for Devices and Drugs for the Years 2015, 2025 & 2030
    • TABLE 53: France Recent Past, Current & Future Analysis for Peripheral Artery Disease by End-user - Specialty Clinics and Hospitals - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 54: France Historic Review for Peripheral Artery Disease by End-user - Specialty Clinics and Hospitals Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 55: France 15-Year Perspective for Peripheral Artery Disease by End-user - Percentage Breakdown of Value Sales for Specialty Clinics and Hospitals for the Years 2015, 2025 & 2030
  • GERMANY
    • Peripheral Artery Disease Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Germany for 2025 (E)
    • TABLE 56: Germany Recent Past, Current & Future Analysis for Peripheral Artery Disease by Product Type - Devices and Drugs - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 57: Germany Historic Review for Peripheral Artery Disease by Product Type - Devices and Drugs Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 58: Germany 15-Year Perspective for Peripheral Artery Disease by Product Type - Percentage Breakdown of Value Sales for Devices and Drugs for the Years 2015, 2025 & 2030
    • TABLE 59: Germany Recent Past, Current & Future Analysis for Peripheral Artery Disease by End-user - Specialty Clinics and Hospitals - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 60: Germany Historic Review for Peripheral Artery Disease by End-user - Specialty Clinics and Hospitals Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 61: Germany 15-Year Perspective for Peripheral Artery Disease by End-user - Percentage Breakdown of Value Sales for Specialty Clinics and Hospitals for the Years 2015, 2025 & 2030
  • ITALY
    • TABLE 62: Italy Recent Past, Current & Future Analysis for Peripheral Artery Disease by Product Type - Devices and Drugs - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 63: Italy Historic Review for Peripheral Artery Disease by Product Type - Devices and Drugs Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 64: Italy 15-Year Perspective for Peripheral Artery Disease by Product Type - Percentage Breakdown of Value Sales for Devices and Drugs for the Years 2015, 2025 & 2030
    • TABLE 65: Italy Recent Past, Current & Future Analysis for Peripheral Artery Disease by End-user - Specialty Clinics and Hospitals - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 66: Italy Historic Review for Peripheral Artery Disease by End-user - Specialty Clinics and Hospitals Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 67: Italy 15-Year Perspective for Peripheral Artery Disease by End-user - Percentage Breakdown of Value Sales for Specialty Clinics and Hospitals for the Years 2015, 2025 & 2030
  • UNITED KINGDOM
    • Peripheral Artery Disease Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United Kingdom for 2025 (E)
    • TABLE 68: UK Recent Past, Current & Future Analysis for Peripheral Artery Disease by Product Type - Devices and Drugs - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 69: UK Historic Review for Peripheral Artery Disease by Product Type - Devices and Drugs Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 70: UK 15-Year Perspective for Peripheral Artery Disease by Product Type - Percentage Breakdown of Value Sales for Devices and Drugs for the Years 2015, 2025 & 2030
    • TABLE 71: UK Recent Past, Current & Future Analysis for Peripheral Artery Disease by End-user - Specialty Clinics and Hospitals - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 72: UK Historic Review for Peripheral Artery Disease by End-user - Specialty Clinics and Hospitals Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 73: UK 15-Year Perspective for Peripheral Artery Disease by End-user - Percentage Breakdown of Value Sales for Specialty Clinics and Hospitals for the Years 2015, 2025 & 2030
  • SPAIN
    • TABLE 74: Spain Recent Past, Current & Future Analysis for Peripheral Artery Disease by Product Type - Devices and Drugs - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 75: Spain Historic Review for Peripheral Artery Disease by Product Type - Devices and Drugs Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 76: Spain 15-Year Perspective for Peripheral Artery Disease by Product Type - Percentage Breakdown of Value Sales for Devices and Drugs for the Years 2015, 2025 & 2030
    • TABLE 77: Spain Recent Past, Current & Future Analysis for Peripheral Artery Disease by End-user - Specialty Clinics and Hospitals - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 78: Spain Historic Review for Peripheral Artery Disease by End-user - Specialty Clinics and Hospitals Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 79: Spain 15-Year Perspective for Peripheral Artery Disease by End-user - Percentage Breakdown of Value Sales for Specialty Clinics and Hospitals for the Years 2015, 2025 & 2030
  • RUSSIA
    • TABLE 80: Russia Recent Past, Current & Future Analysis for Peripheral Artery Disease by Product Type - Devices and Drugs - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 81: Russia Historic Review for Peripheral Artery Disease by Product Type - Devices and Drugs Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 82: Russia 15-Year Perspective for Peripheral Artery Disease by Product Type - Percentage Breakdown of Value Sales for Devices and Drugs for the Years 2015, 2025 & 2030
    • TABLE 83: Russia Recent Past, Current & Future Analysis for Peripheral Artery Disease by End-user - Specialty Clinics and Hospitals - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 84: Russia Historic Review for Peripheral Artery Disease by End-user - Specialty Clinics and Hospitals Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 85: Russia 15-Year Perspective for Peripheral Artery Disease by End-user - Percentage Breakdown of Value Sales for Specialty Clinics and Hospitals for the Years 2015, 2025 & 2030
  • REST OF EUROPE
    • TABLE 86: Rest of Europe Recent Past, Current & Future Analysis for Peripheral Artery Disease by Product Type - Devices and Drugs - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 87: Rest of Europe Historic Review for Peripheral Artery Disease by Product Type - Devices and Drugs Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 88: Rest of Europe 15-Year Perspective for Peripheral Artery Disease by Product Type - Percentage Breakdown of Value Sales for Devices and Drugs for the Years 2015, 2025 & 2030
    • TABLE 89: Rest of Europe Recent Past, Current & Future Analysis for Peripheral Artery Disease by End-user - Specialty Clinics and Hospitals - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 90: Rest of Europe Historic Review for Peripheral Artery Disease by End-user - Specialty Clinics and Hospitals Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 91: Rest of Europe 15-Year Perspective for Peripheral Artery Disease by End-user - Percentage Breakdown of Value Sales for Specialty Clinics and Hospitals for the Years 2015, 2025 & 2030
  • ASIA-PACIFIC
    • Peripheral Artery Disease Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Asia-Pacific for 2025 (E)
    • TABLE 92: Asia-Pacific Recent Past, Current & Future Analysis for Peripheral Artery Disease by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 93: Asia-Pacific Historic Review for Peripheral Artery Disease by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 94: Asia-Pacific 15-Year Perspective for Peripheral Artery Disease by Geographic Region - Percentage Breakdown of Value Sales for Australia, India, South Korea and Rest of Asia-Pacific Markets for Years 2015, 2025 & 2030
    • TABLE 95: Asia-Pacific Recent Past, Current & Future Analysis for Peripheral Artery Disease by Product Type - Devices and Drugs - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 96: Asia-Pacific Historic Review for Peripheral Artery Disease by Product Type - Devices and Drugs Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 97: Asia-Pacific 15-Year Perspective for Peripheral Artery Disease by Product Type - Percentage Breakdown of Value Sales for Devices and Drugs for the Years 2015, 2025 & 2030
    • TABLE 98: Asia-Pacific Recent Past, Current & Future Analysis for Peripheral Artery Disease by End-user - Specialty Clinics and Hospitals - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 99: Asia-Pacific Historic Review for Peripheral Artery Disease by End-user - Specialty Clinics and Hospitals Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 100: Asia-Pacific 15-Year Perspective for Peripheral Artery Disease by End-user - Percentage Breakdown of Value Sales for Specialty Clinics and Hospitals for the Years 2015, 2025 & 2030
  • AUSTRALIA
    • Peripheral Artery Disease Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Australia for 2025 (E)
    • TABLE 101: Australia Recent Past, Current & Future Analysis for Peripheral Artery Disease by Product Type - Devices and Drugs - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 102: Australia Historic Review for Peripheral Artery Disease by Product Type - Devices and Drugs Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 103: Australia 15-Year Perspective for Peripheral Artery Disease by Product Type - Percentage Breakdown of Value Sales for Devices and Drugs for the Years 2015, 2025 & 2030
    • TABLE 104: Australia Recent Past, Current & Future Analysis for Peripheral Artery Disease by End-user - Specialty Clinics and Hospitals - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 105: Australia Historic Review for Peripheral Artery Disease by End-user - Specialty Clinics and Hospitals Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 106: Australia 15-Year Perspective for Peripheral Artery Disease by End-user - Percentage Breakdown of Value Sales for Specialty Clinics and Hospitals for the Years 2015, 2025 & 2030
  • INDIA
    • Peripheral Artery Disease Market Presence - Strong/Active/Niche/Trivial - Key Competitors in India for 2025 (E)
    • TABLE 107: India Recent Past, Current & Future Analysis for Peripheral Artery Disease by Product Type - Devices and Drugs - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 108: India Historic Review for Peripheral Artery Disease by Product Type - Devices and Drugs Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 109: India 15-Year Perspective for Peripheral Artery Disease by Product Type - Percentage Breakdown of Value Sales for Devices and Drugs for the Years 2015, 2025 & 2030
    • TABLE 110: India Recent Past, Current & Future Analysis for Peripheral Artery Disease by End-user - Specialty Clinics and Hospitals - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 111: India Historic Review for Peripheral Artery Disease by End-user - Specialty Clinics and Hospitals Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 112: India 15-Year Perspective for Peripheral Artery Disease by End-user - Percentage Breakdown of Value Sales for Specialty Clinics and Hospitals for the Years 2015, 2025 & 2030
  • SOUTH KOREA
    • TABLE 113: South Korea Recent Past, Current & Future Analysis for Peripheral Artery Disease by Product Type - Devices and Drugs - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 114: South Korea Historic Review for Peripheral Artery Disease by Product Type - Devices and Drugs Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 115: South Korea 15-Year Perspective for Peripheral Artery Disease by Product Type - Percentage Breakdown of Value Sales for Devices and Drugs for the Years 2015, 2025 & 2030
    • TABLE 116: South Korea Recent Past, Current & Future Analysis for Peripheral Artery Disease by End-user - Specialty Clinics and Hospitals - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 117: South Korea Historic Review for Peripheral Artery Disease by End-user - Specialty Clinics and Hospitals Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 118: South Korea 15-Year Perspective for Peripheral Artery Disease by End-user - Percentage Breakdown of Value Sales for Specialty Clinics and Hospitals for the Years 2015, 2025 & 2030
  • REST OF ASIA-PACIFIC
    • TABLE 119: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Peripheral Artery Disease by Product Type - Devices and Drugs - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 120: Rest of Asia-Pacific Historic Review for Peripheral Artery Disease by Product Type - Devices and Drugs Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 121: Rest of Asia-Pacific 15-Year Perspective for Peripheral Artery Disease by Product Type - Percentage Breakdown of Value Sales for Devices and Drugs for the Years 2015, 2025 & 2030
    • TABLE 122: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Peripheral Artery Disease by End-user - Specialty Clinics and Hospitals - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 123: Rest of Asia-Pacific Historic Review for Peripheral Artery Disease by End-user - Specialty Clinics and Hospitals Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 124: Rest of Asia-Pacific 15-Year Perspective for Peripheral Artery Disease by End-user - Percentage Breakdown of Value Sales for Specialty Clinics and Hospitals for the Years 2015, 2025 & 2030
  • LATIN AMERICA
    • Peripheral Artery Disease Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Latin America for 2025 (E)
    • TABLE 125: Latin America Recent Past, Current & Future Analysis for Peripheral Artery Disease by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 126: Latin America Historic Review for Peripheral Artery Disease by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 127: Latin America 15-Year Perspective for Peripheral Artery Disease by Geographic Region - Percentage Breakdown of Value Sales for Argentina, Brazil, Mexico and Rest of Latin America Markets for Years 2015, 2025 & 2030
    • TABLE 128: Latin America Recent Past, Current & Future Analysis for Peripheral Artery Disease by Product Type - Devices and Drugs - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 129: Latin America Historic Review for Peripheral Artery Disease by Product Type - Devices and Drugs Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 130: Latin America 15-Year Perspective for Peripheral Artery Disease by Product Type - Percentage Breakdown of Value Sales for Devices and Drugs for the Years 2015, 2025 & 2030
    • TABLE 131: Latin America Recent Past, Current & Future Analysis for Peripheral Artery Disease by End-user - Specialty Clinics and Hospitals - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 132: Latin America Historic Review for Peripheral Artery Disease by End-user - Specialty Clinics and Hospitals Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 133: Latin America 15-Year Perspective for Peripheral Artery Disease by End-user - Percentage Breakdown of Value Sales for Specialty Clinics and Hospitals for the Years 2015, 2025 & 2030
  • ARGENTINA
    • TABLE 134: Argentina Recent Past, Current & Future Analysis for Peripheral Artery Disease by Product Type - Devices and Drugs - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 135: Argentina Historic Review for Peripheral Artery Disease by Product Type - Devices and Drugs Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 136: Argentina 15-Year Perspective for Peripheral Artery Disease by Product Type - Percentage Breakdown of Value Sales for Devices and Drugs for the Years 2015, 2025 & 2030
    • TABLE 137: Argentina Recent Past, Current & Future Analysis for Peripheral Artery Disease by End-user - Specialty Clinics and Hospitals - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 138: Argentina Historic Review for Peripheral Artery Disease by End-user - Specialty Clinics and Hospitals Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 139: Argentina 15-Year Perspective for Peripheral Artery Disease by End-user - Percentage Breakdown of Value Sales for Specialty Clinics and Hospitals for the Years 2015, 2025 & 2030
  • BRAZIL
    • TABLE 140: Brazil Recent Past, Current & Future Analysis for Peripheral Artery Disease by Product Type - Devices and Drugs - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 141: Brazil Historic Review for Peripheral Artery Disease by Product Type - Devices and Drugs Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 142: Brazil 15-Year Perspective for Peripheral Artery Disease by Product Type - Percentage Breakdown of Value Sales for Devices and Drugs for the Years 2015, 2025 & 2030
    • TABLE 143: Brazil Recent Past, Current & Future Analysis for Peripheral Artery Disease by End-user - Specialty Clinics and Hospitals - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 144: Brazil Historic Review for Peripheral Artery Disease by End-user - Specialty Clinics and Hospitals Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 145: Brazil 15-Year Perspective for Peripheral Artery Disease by End-user - Percentage Breakdown of Value Sales for Specialty Clinics and Hospitals for the Years 2015, 2025 & 2030
  • MEXICO
    • TABLE 146: Mexico Recent Past, Current & Future Analysis for Peripheral Artery Disease by Product Type - Devices and Drugs - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 147: Mexico Historic Review for Peripheral Artery Disease by Product Type - Devices and Drugs Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 148: Mexico 15-Year Perspective for Peripheral Artery Disease by Product Type - Percentage Breakdown of Value Sales for Devices and Drugs for the Years 2015, 2025 & 2030
    • TABLE 149: Mexico Recent Past, Current & Future Analysis for Peripheral Artery Disease by End-user - Specialty Clinics and Hospitals - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 150: Mexico Historic Review for Peripheral Artery Disease by End-user - Specialty Clinics and Hospitals Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 151: Mexico 15-Year Perspective for Peripheral Artery Disease by End-user - Percentage Breakdown of Value Sales for Specialty Clinics and Hospitals for the Years 2015, 2025 & 2030
  • REST OF LATIN AMERICA
    • TABLE 152: Rest of Latin America Recent Past, Current & Future Analysis for Peripheral Artery Disease by Product Type - Devices and Drugs - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 153: Rest of Latin America Historic Review for Peripheral Artery Disease by Product Type - Devices and Drugs Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 154: Rest of Latin America 15-Year Perspective for Peripheral Artery Disease by Product Type - Percentage Breakdown of Value Sales for Devices and Drugs for the Years 2015, 2025 & 2030
    • TABLE 155: Rest of Latin America Recent Past, Current & Future Analysis for Peripheral Artery Disease by End-user - Specialty Clinics and Hospitals - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 156: Rest of Latin America Historic Review for Peripheral Artery Disease by End-user - Specialty Clinics and Hospitals Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 157: Rest of Latin America 15-Year Perspective for Peripheral Artery Disease by End-user - Percentage Breakdown of Value Sales for Specialty Clinics and Hospitals for the Years 2015, 2025 & 2030
  • MIDDLE EAST
    • Peripheral Artery Disease Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Middle East for 2025 (E)
    • TABLE 158: Middle East Recent Past, Current & Future Analysis for Peripheral Artery Disease by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 159: Middle East Historic Review for Peripheral Artery Disease by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 160: Middle East 15-Year Perspective for Peripheral Artery Disease by Geographic Region - Percentage Breakdown of Value Sales for Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets for Years 2015, 2025 & 2030
    • TABLE 161: Middle East Recent Past, Current & Future Analysis for Peripheral Artery Disease by Product Type - Devices and Drugs - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 162: Middle East Historic Review for Peripheral Artery Disease by Product Type - Devices and Drugs Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 163: Middle East 15-Year Perspective for Peripheral Artery Disease by Product Type - Percentage Breakdown of Value Sales for Devices and Drugs for the Years 2015, 2025 & 2030
    • TABLE 164: Middle East Recent Past, Current & Future Analysis for Peripheral Artery Disease by End-user - Specialty Clinics and Hospitals - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 165: Middle East Historic Review for Peripheral Artery Disease by End-user - Specialty Clinics and Hospitals Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 166: Middle East 15-Year Perspective for Peripheral Artery Disease by End-user - Percentage Breakdown of Value Sales for Specialty Clinics and Hospitals for the Years 2015, 2025 & 2030
  • IRAN
    • TABLE 167: Iran Recent Past, Current & Future Analysis for Peripheral Artery Disease by Product Type - Devices and Drugs - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 168: Iran Historic Review for Peripheral Artery Disease by Product Type - Devices and Drugs Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 169: Iran 15-Year Perspective for Peripheral Artery Disease by Product Type - Percentage Breakdown of Value Sales for Devices and Drugs for the Years 2015, 2025 & 2030
    • TABLE 170: Iran Recent Past, Current & Future Analysis for Peripheral Artery Disease by End-user - Specialty Clinics and Hospitals - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 171: Iran Historic Review for Peripheral Artery Disease by End-user - Specialty Clinics and Hospitals Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 172: Iran 15-Year Perspective for Peripheral Artery Disease by End-user - Percentage Breakdown of Value Sales for Specialty Clinics and Hospitals for the Years 2015, 2025 & 2030
  • ISRAEL
    • TABLE 173: Israel Recent Past, Current & Future Analysis for Peripheral Artery Disease by Product Type - Devices and Drugs - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 174: Israel Historic Review for Peripheral Artery Disease by Product Type - Devices and Drugs Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 175: Israel 15-Year Perspective for Peripheral Artery Disease by Product Type - Percentage Breakdown of Value Sales for Devices and Drugs for the Years 2015, 2025 & 2030
    • TABLE 176: Israel Recent Past, Current & Future Analysis for Peripheral Artery Disease by End-user - Specialty Clinics and Hospitals - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 177: Israel Historic Review for Peripheral Artery Disease by End-user - Specialty Clinics and Hospitals Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 178: Israel 15-Year Perspective for Peripheral Artery Disease by End-user - Percentage Breakdown of Value Sales for Specialty Clinics and Hospitals for the Years 2015, 2025 & 2030
  • SAUDI ARABIA
    • TABLE 179: Saudi Arabia Recent Past, Current & Future Analysis for Peripheral Artery Disease by Product Type - Devices and Drugs - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 180: Saudi Arabia Historic Review for Peripheral Artery Disease by Product Type - Devices and Drugs Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 181: Saudi Arabia 15-Year Perspective for Peripheral Artery Disease by Product Type - Percentage Breakdown of Value Sales for Devices and Drugs for the Years 2015, 2025 & 2030
    • TABLE 182: Saudi Arabia Recent Past, Current & Future Analysis for Peripheral Artery Disease by End-user - Specialty Clinics and Hospitals - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 183: Saudi Arabia Historic Review for Peripheral Artery Disease by End-user - Specialty Clinics and Hospitals Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 184: Saudi Arabia 15-Year Perspective for Peripheral Artery Disease by End-user - Percentage Breakdown of Value Sales for Specialty Clinics and Hospitals for the Years 2015, 2025 & 2030
  • UNITED ARAB EMIRATES
    • TABLE 185: UAE Recent Past, Current & Future Analysis for Peripheral Artery Disease by Product Type - Devices and Drugs - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 186: UAE Historic Review for Peripheral Artery Disease by Product Type - Devices and Drugs Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 187: UAE 15-Year Perspective for Peripheral Artery Disease by Product Type - Percentage Breakdown of Value Sales for Devices and Drugs for the Years 2015, 2025 & 2030
    • TABLE 188: UAE Recent Past, Current & Future Analysis for Peripheral Artery Disease by End-user - Specialty Clinics and Hospitals - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 189: UAE Historic Review for Peripheral Artery Disease by End-user - Specialty Clinics and Hospitals Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 190: UAE 15-Year Perspective for Peripheral Artery Disease by End-user - Percentage Breakdown of Value Sales for Specialty Clinics and Hospitals for the Years 2015, 2025 & 2030
  • REST OF MIDDLE EAST
    • TABLE 191: Rest of Middle East Recent Past, Current & Future Analysis for Peripheral Artery Disease by Product Type - Devices and Drugs - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 192: Rest of Middle East Historic Review for Peripheral Artery Disease by Product Type - Devices and Drugs Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 193: Rest of Middle East 15-Year Perspective for Peripheral Artery Disease by Product Type - Percentage Breakdown of Value Sales for Devices and Drugs for the Years 2015, 2025 & 2030
    • TABLE 194: Rest of Middle East Recent Past, Current & Future Analysis for Peripheral Artery Disease by End-user - Specialty Clinics and Hospitals - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 195: Rest of Middle East Historic Review for Peripheral Artery Disease by End-user - Specialty Clinics and Hospitals Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 196: Rest of Middle East 15-Year Perspective for Peripheral Artery Disease by End-user - Percentage Breakdown of Value Sales for Specialty Clinics and Hospitals for the Years 2015, 2025 & 2030
  • AFRICA
    • Peripheral Artery Disease Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Africa for 2025 (E)
    • TABLE 197: Africa Recent Past, Current & Future Analysis for Peripheral Artery Disease by Product Type - Devices and Drugs - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 198: Africa Historic Review for Peripheral Artery Disease by Product Type - Devices and Drugs Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 199: Africa 15-Year Perspective for Peripheral Artery Disease by Product Type - Percentage Breakdown of Value Sales for Devices and Drugs for the Years 2015, 2025 & 2030
    • TABLE 200: Africa Recent Past, Current & Future Analysis for Peripheral Artery Disease by End-user - Specialty Clinics and Hospitals - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 201: Africa Historic Review for Peripheral Artery Disease by End-user - Specialty Clinics and Hospitals Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 202: Africa 15-Year Perspective for Peripheral Artery Disease by End-user - Percentage Breakdown of Value Sales for Specialty Clinics and Hospitals for the Years 2015, 2025 & 2030

IV. COMPETITION